• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLOS Digit Health . Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19

tetano

Editor, Senior Moderator
PLOS Digit Health


. 2022 Aug 1;1(8):e0000057.
doi: 10.1371/journal.pdig.0000057. eCollection 2022 Aug.
Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19


Ayis Pyrros[SUP] 1 [/SUP], Jorge Rodriguez Fernandez[SUP] 2 [/SUP], Stephen M Borstelmann[SUP] 3 [/SUP], Adam Flanders[SUP] 4 [/SUP], Daniel Wenzke[SUP] 5 [/SUP], Eric Hart[SUP] 6 [/SUP], Jeanne M Horowitz[SUP] 6 [/SUP], Paul Nikolaidis[SUP] 6 [/SUP], Melinda Willis[SUP] 1 [/SUP], Andrew Chen[SUP] 7 [/SUP], Patrick Cole[SUP] 7 [/SUP], Nasir Siddiqui[SUP] 1 [/SUP], Momin Muzaffar[SUP] 1 [/SUP], Nadir Muzaffar[SUP] 1 [/SUP], Jennifer McVean[SUP] 8 [/SUP], Martha Menchaca[SUP] 9 [/SUP], Aggelos K Katsaggelos[SUP] 10 [/SUP], Sanmi Koyejo[SUP] 7 [/SUP], William Galanter[SUP] 11 [/SUP]



Affiliations

Abstract

We validate a deep learning model predicting comorbidities from frontal chest radiographs (CXRs) in patients with coronavirus disease 2019 (COVID-19) and compare the model's performance with hierarchical condition category (HCC) and mortality outcomes in COVID-19. The model was trained and tested on 14,121 ambulatory frontal CXRs from 2010 to 2019 at a single institution, modeling select comorbidities using the value-based Medicare Advantage HCC Risk Adjustment Model. Sex, age, HCC codes, and risk adjustment factor (RAF) score were used. The model was validated on frontal CXRs from 413 ambulatory patients with COVID-19 (internal cohort) and on initial frontal CXRs from 487 COVID-19 hospitalized patients (external cohort). The discriminatory ability of the model was assessed using receiver operating characteristic (ROC) curves compared to the HCC data from electronic health records, and predicted age and RAF score were compared using correlation coefficient and absolute mean error. The model predictions were used as covariables in logistic regression models to evaluate the prediction of mortality in the external cohort. Predicted comorbidities from frontal CXRs, including diabetes with chronic complications, obesity, congestive heart failure, arrhythmias, vascular disease, and chronic obstructive pulmonary disease, had a total area under ROC curve (AUC) of 0.85 (95% CI: 0.85-0.86). The ROC AUC of predicted mortality for the model was 0.84 (95% CI,0.79-0.88) for the combined cohorts. This model using only frontal CXRs predicted select comorbidities and RAF score in both internal ambulatory and external hospitalized COVID-19 cohorts and was discriminatory of mortality, supporting its potential use in clinical decision making.
 
Back
Top Bottom